Code Biotherapeutics

Code Biotherapeutics

Developing next-generation gene therapies for patients with rare and prevalent genetic diseases. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
€273—409m (Dealroom.co estimates Jun 2022.)
Hatfield Minnesota (HQ)
Authorizing premium user...